Literature DB >> 19914399

The biliprotein C-phycocyanin modulates the early radiation response: a pilot study.

Katia G Ivanova1, Katia G Stankova, Vladimir N Nikolov, Radostina T Georgieva, Kaledona M Minkova, Lili G Gigova, Ivanka T Rupova, Rayna N Boteva.   

Abstract

This study analyzed the effects of biliprotein C-phycocyanin (C-PC) on the enzymatic antioxidant defence system in lymphocytes of nuclear power-plant workers and non-exposed controls. Changes in the protein levels of manganese super oxide dismutase (MnSOD), catalase and glutathione-S-transferase (GST) were used as markers for early biological effects of a single in vitro exposure of cells to: (i) 2Gy gamma rays; (ii) 5muM C-PC; and (iii) a combination of C-PC plus irradiation with 2Gy. The results showed that C-PC selectively stimulated the lymphocyte antioxidant defence system of occupationally exposed subjects. The activation of the antioxidant protective mechanisms as part of the early radiation response was probably related to the chronic low-dose occupational exposure. The modulating capacity of C-PC at the molecular level may be of interest for the protection of occupationally exposed persons. Copyright 2009 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19914399     DOI: 10.1016/j.mrgentox.2009.11.002

Source DB:  PubMed          Journal:  Mutat Res        ISSN: 0027-5107            Impact factor:   2.433


  3 in total

1.  Efficacy of red light for enhanced cell disruption and fluorescence intensity of phycocyanin.

Authors:  Sivaprakasam Sivasankari; Mani Vinoth; David Ravindran; Kathirvelu Baskar; Abdulaziz A Alqarawi; Elsayed Fathi Abd Allah
Journal:  Bioprocess Biosyst Eng       Date:  2020-09-04       Impact factor: 3.210

Review 2.  Phycobiliproteins-A Family of Algae-Derived Biliproteins: Productions, Characterization and Pharmaceutical Potentials.

Authors:  Huaxin Chen; Hongtao Qi; Peng Xiong
Journal:  Mar Drugs       Date:  2022-07-09       Impact factor: 6.085

3.  HSP90 Inhibitor Geldanamycin as a Radiation Response Modificator in Human Blood Cells.

Authors:  Katia Stankova; Gergana Savova; Vladimir Nikolov; Rayna Boteva
Journal:  Dose Response       Date:  2015-05-04       Impact factor: 2.658

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.